UBS AG - DURATA THERAPEUTICS INC ownership

DURATA THERAPEUTICS INC's ticker is DRTX and the CUSIP is 26658A107. A total of 46 filers reported holding DURATA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
UBS AG ownership history of DURATA THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$1,603,000
-12.5%
126,351
+17.4%
0.00%0.0%
Q2 2014$1,833,000
+15175.0%
107,666
+12065.6%
0.00%
Q1 2014$12,000
+140.0%
885
+114.3%
0.00%
Q4 2013$5,000
-68.8%
413
-76.7%
0.00%
Q3 2013$16,0001,7700.00%
Other shareholders
DURATA THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Canaan Partners VII LLC 1,902,030$24,118,00041.13%
Aisling Capital LLC 2,030,175$25,740,0004.99%
EAM Investors, LLC 187,925$2,383,0000.48%
Granahan Investment Management 691,283$8,765,0000.27%
Orbimed Advisors 1,785,714$22,643,0000.24%
Lenox Wealth Advisors, LLC 11,000$139,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 76,150$966,0000.02%
PDT Partners, LLC 61,331$778,0000.02%
MAGEE THOMSON INVESTMENT PARTNERS LLC 5,022$63,0000.02%
MASON STREET ADVISORS, LLC 148,533$1,883,0000.02%
View complete list of DURATA THERAPEUTICS INC shareholders